Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2025-12-25 @ 7:40 PM
Study NCT ID:
NCT03482635
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2018-03-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-15
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-18
Results First Submit QC Date:
None
Results First Post Date:
2021-06-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED